Huntington's disease: open trials in Denmark

• 2026-526408-60-00

  A Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3

  Trial Treatment · Phase 2 · Vico Therapeutics B.V.

  Region Hovedstaden, Copenhagen Oe

  Registry updated 2026-10-30

• NCT07326709

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-09-22

• NCT05822908

  A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

  Trial Treatment · Phase 1/2 · Vico Therapeutics B. V.

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-08-19

• NCT01574053

  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  Research · CHDI Foundation, Inc.

  University Hospital of Aarhus, Aarhus · University Hospital of Copenhagen, Copenhagen · University Hospital of Odense, Odense

  Registry updated 2024-02-28

All Huntington's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error